Identification of novel proteomic biomarkers for hypertension: a targeted approach for precision medicine
Views
0% 0
Downloads
0 0%
Open access
Citation
Rana S. Aldisi, Alsamman M. Alsamman, Peter Krawitz, Carlo Maj, Hatem Zayed. (12/2/2025). Identification of novel proteomic biomarkers for hypertension: a targeted approach for precision medicine. Clinical Proteomics, 22.
Abstract
Background
Hypertension is a critical public health issue worldwide. The identification of specific proteomic biomarkers in the Qatari population aims to advance personalized treatment strategies.
Methods
We conducted proteomic profiling on 778 Qatari individuals using an aptamer-based SOMAscan platform to analyze 1,305 biomarkers. Statistical analysis involved two-way ANOVA and association analyses with FDR correction, alongside pathway and gene-set enrichment analyses using Reactome and DisGeNET databases.
Results
The study identified 26 significant protein biomarkers associated with hypertension. Notably, QORL1 and BMP1 were identified as novel protein biomarkers. Enrichment analysis linked these biomarkers to critical pathways involved in vascular biology, immune system responses, and pathologies like arteriosclerosis and coronary artery disease. Correlation analyses highlighted robust interactions, particularly between QORL1 and various Apolipoprotein E isoforms, suggesting these biomarkers play pivotal roles in the molecular mechanisms underlying hypertension.
